Corporate Tech Investors

ShangPharma Investment Group

ShangPharma Investment Group is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

The service division of the ShangPharma group, ChemPartner, is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. The company offers a broad range of high-quality, integrated services across the drug discovery and development process to pharmaceutical and biotechnology companies around the globe. ChemPartner's services consist of discovery biologics, discovery chemistry, discovery biology and preclinical development, pharmaceutical development, small molecule and biologics manufacturing services.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/18/2020

Transaction History

Our records indicate that ShangPharma Investment Group invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Hui Xin

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

ShangPharma Investment Group has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Shanghai Sinobioway Sunterra Biotechnology | ShapeShift

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary